Biotech

All Articles

Vaderis' rare blood vessel disorder medication reduces nosebleeds

.Vaderis Rehabs' target to create the very first drug aimed exclusively at a particular uncommon cap...

Navigator rears $100M to develop brand-new autoimmune pipeline

.Navigator Medicines has actually equipped on its own with $100 thousand in collection A funds as th...

Duality seeks money for ADC trials as IPO surge spreads to Asia

.China's Duality Biotherapeutics has actually submitted (PDF) documentation for a Hong Kong IPO, loo...

YolTech sells China rights to gene modifying treatment for $29M

.Four months after Chinese genetics editing firm YolTech Therapeutics took its own cholesterol disea...

Addex stock rises after Indivior offers up to $300M for compound

.Indivior is picking up a little particle allosteric modulator designed to deal with compound use di...

Molecular Allies fine-tunes AML trial over 'suboptimal direct exposure'

.Molecular Partners has actually pinpointed "suboptimal exposure" to its own tetra-specific T-cell e...

Despite combined market, a venture capital revival could be can be found in Europe: PitchBook

.While the biotech investment scene in Europe has slowed rather following a COVID-19 financing boom ...

8 months after a $213M fundraise, gene publisher Tome creates reduces

.After raising $213 million in 2023-- some of the year's largest personal biotech shots-- Tome Biosc...

BioMarin builds officer team with biotech vets-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Biopharma Q2 VC struck highest degree because '22, while M&ampA decreased

.Financial backing funding in to biopharma cheered $9.2 billion around 215 sell the second one-fourt...